TORRIE FURMAN: Open Payments
NPI 1932489325 · OWINGSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 22 payments from 12 companies in 2025. Trend: 2023 $226 · 2024 $313 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $104 |
| Endo USA, Inc. | 4 | $94 |
| UROGEN PHARMA, INC. | 3 | $75 |
| Astellas Pharma US Inc | 3 | $61 |
| COLOPLAST CORP | 1 | $29 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
| Calyxo, Inc. | 1 | $21 |
| Procept Biorobotics Corporation | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Davol Inc. | 1 | $17 |
Products named: XIAFLEX, GEMTESA, Xtandi, JELMYTO, Luja Coude, ORGOVYX, PYLARIFY, CVAC ASPIRATION SYSTEM.
Industry payments across KY — which companies pay providers there.
